(Q42284108)

English

Long-term CD4(+) and CD8(+) T-cell responses induced in HIV-uninfected volunteers following intradermal or intramuscular administration of an HIV-lipopeptide vaccine (ANRS VAC16).

scientific article published on 11 July 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 October 2017

Long-term CD4(+) and CD8(+) T-cell responses induced in HIV-uninfected volunteers following intradermal or intramuscular administration of an HIV-lipopeptide vaccine (ANRS VAC16). (English)

1 reference

Europe PubMed Central

19 October 2017

9

1 reference

Europe PubMed Central

19 October 2017

Isabelle Poizot-Martin

7

object named as

Isabelle Poizot-Martin

1 reference

Europe PubMed Central

19 October 2017

Gustavo Francisco Gonzáles

object named as

Gustavo Gonzales

8

0 references

1

object named as

Odile Launay

1 reference

Europe PubMed Central

19 October 2017

author name string

Mathieu Surenaud

2

1 reference

Europe PubMed Central

19 October 2017

Corinne Desaint

3

1 reference

Europe PubMed Central

19 October 2017

Nadine Ben Hamouda

4

1 reference

Europe PubMed Central

19 October 2017

Gilles Pialoux

5

1 reference

Europe PubMed Central

19 October 2017

Bénédicte Bonnet

6

1 reference

Europe PubMed Central

19 October 2017

Isabelle Bourgault-Villada

10

1 reference

Europe PubMed Central

19 October 2017

Yves Lévy

11

1 reference

Europe PubMed Central

19 October 2017

Jeannine Choppin

12

1 reference

Europe PubMed Central

19 October 2017

Christine Durier

13

1 reference

Europe PubMed Central

19 October 2017

language of work or name

0 references

publication date

11 July 2013

1 reference

Europe PubMed Central

19 October 2017

1 reference

Europe PubMed Central

19 October 2017

31

1 reference

Europe PubMed Central

19 October 2017

40

1 reference

Europe PubMed Central

19 October 2017

4406-4415

1 reference

Europe PubMed Central

19 October 2017

Characterization of a multi-lipopeptides mixture used as an HIV-1 vaccine candidate

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.102

7 January 2021

Multiepitopic B- and T-cell responses induced in humans by a human immunodeficiency virus type 1 lipopeptide vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.102

7 January 2021

Lipopeptides induce cell-mediated anti-HIV immune responses in seronegative volunteers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.102

7 January 2021

Long-term specific immune responses induced in humans by a human immunodeficiency virus type 1 lipopeptide vaccine: characterization of CD8+-T-cell epitopes recognized.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.102

7 January 2021

Sustained control of viremia following therapeutic immunization in chronically HIV-1-infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.102

7 January 2021

New CD4+ and CD8+ T cell responses induced in chronically HIV type-1-infected patients after immunizations with an HIV type 1 lipopeptide vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.102

7 January 2021

Immunological responses and long-term treatment interruption after human immunodeficiency virus type 1 (HIV-1) lipopeptide immunization of HIV-1-infected patients: the LIPTHERA study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.102

7 January 2021

Targeting antigen in mature dendritic cells for simultaneous stimulation of CD4+ and CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.102

7 January 2021

Endocytosis of an HIV-derived lipopeptide into human dendritic cells followed by class I-restricted CD8(+) T lymphocyte activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.102

7 January 2021

Two human immunodeficiency virus vaccinal lipopeptides follow different cross-presentation pathways in human dendritic cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.102

7 January 2021

Clinical evaluation of low-dose intradermally administered hepatitis B virus vaccine. A cost reduction strategy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.102

7 January 2021

Low-dose intradermal and intramuscular vaccination against hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.102

7 January 2021

Serum antibody responses after intradermal vaccination against influenza

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.102

7 January 2021

Dose sparing with intradermal injection of influenza vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.102

7 January 2021

Effect of vaccination route and composition of DNA vaccine on the induction of protective immunity against pseudorabies infection in pigs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.102

7 January 2021

Superiority of the ear pinna over muscle tissue as site for DNA vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.102

7 January 2021

DNA immunization via intramuscular and intradermal routes using a gene gun provides different magnitudes and durations on immune response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.102

7 January 2021

Canine rabies DNA vaccination: a single-dose intradermal injection into ear pinnae elicits elevated and persistent levels of neutralizing antibody

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.102

7 January 2021

Optimization of DNA vaccination against cutaneous leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.102

7 January 2021

Cellular immune responses induced with dose-sparing intradermal administration of HIV vaccine to HIV-uninfected volunteers in the ANRS VAC16 trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.102

7 January 2021

Induction of CTL response by a minimal epitope vaccine in HLA A*0201/DR1 transgenic mice: dependence on HLA class II restricted T(H) response.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.102

7 January 2021

Comparative efficiency of simple lipopeptide constructs for in vivo induction of virus-specific CTL.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.102

7 January 2021

Lipopeptide epitopes extended by an Nepsilon-palmitoyl-lysine moiety increase uptake and maturation of dendritic cells through a Toll-like receptor-2 pathway and trigger a Th1-dependent protective immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.102

7 January 2021

Long-lasting anti-viral cytotoxic T lymphocytes induced in vivo with chimeric-multirestricted lipopeptides

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.102

7 January 2021

Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.102

7 January 2021

Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.102

7 January 2021

Dendritic cells and the control of immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.102

7 January 2021

Macrophages and dendritic cells in normal and regenerating murine skeletal muscle

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.102

7 January 2021

Immunobiology of muscle: advances in understanding an immunological microenvironment

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.102

7 January 2021

Immune surveillance in the skin: mechanisms and clinical consequences

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.102

7 January 2021

Cutaneous dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.102

7 January 2021

Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.102

7 January 2021

Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis B vaccine regimen in adults with HIV-1: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.102

7 January 2021

Intradermal hepatitis B vaccination: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.102

7 January 2021

Broad and potent immune responses to a low dose intradermal HIV-1 DNA boosted with HIV-1 recombinant MVA among healthy adults in Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.102

7 January 2021

Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.102

7 January 2021

Multifunctional T-cell characteristics induced by a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 vaccine regimen given to healthy adults are dependent on the route and dose of administration

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.102

7 January 2021

Cellular and humoral immune responses induced by intradermal or intramuscular vaccination with the major hepatitis B surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.102

7 January 2021

Transcutaneous anti-influenza vaccination promotes both CD4 and CD8 T cell immune responses in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.102

7 January 2021

Durable human memory T cells quantifiable by cultured enzyme-linked immunospot assays are induced by heterologous prime boost immunization and correlate with protection against malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.102

7 January 2021

Increased detection of proliferating, polyfunctional, HIV-1-specific T cells in DNA-modified vaccinia virus Ankara-vaccinated human volunteers by cultured IFN-gamma ELISPOT assay

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.102

7 January 2021

Targeting of HIV-p24 particle-based vaccine into differential skin layers induces distinct arms of the immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.102

7 January 2021

Intradermal immunization triggers epidermal Langerhans cell mobilization required for CD8 T-cell immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.102

7 January 2021

Indicators of therapeutic effect in FIT-06, a Phase II trial of a DNA vaccine, GTU(®)-Multi-HIVB, in untreated HIV-1 infected subjects

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.102

7 January 2021

HLA Alleles Associated with Delayed Progression to AIDS Contribute Strongly to the Initial CD8(+) T Cell Response against HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.102

7 January 2021

Absence of Immunodominant Anti-Gag p17 (SL9) Responses among Gag CTL-Positive, HIV-Uninfected Vaccine Recipients Expressing the HLA-A*0201 Allele

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.102

7 January 2021

Dynamics of the CD8 T-cell response following yellow fever virus 17D immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.102

7 January 2021

Antibody production to the nucleocapsid and envelope of the hepatitis B virus primed by a single synthetic T cell site

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.102

7 January 2021

Single-epitope DNA vaccination prevents exhaustion and facilitates a broad antiviral CD8+ T cell response during chronic viral infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.102

7 January 2021

A phase I clinical trial of dendritic cell immunotherapy in HCV-infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.102

7 January 2021

PD-L1 co-stimulation contributes to ligand-induced T cell receptor down-modulation on CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.102

7 January 2021

Regulatory T cells suppress natural killer cells during plasmid DNA vaccination in mice, blunting the CD8+ T cell immune response by the cytokine TGFbeta

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.102

7 January 2021

WT1 peptide vaccination in a CML patient: induction of effective cytotoxic T lymphocytes and significance of peptide administration interval.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.102

7 January 2021

Immunogenicity and safety of an HIV-1 lipopeptide vaccine in healthy adults: a phase 2 placebo-controlled ANRS trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.102

7 January 2021

Development of a HIV-1 lipopeptide antigen pulsed therapeutic dendritic cell vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.102

7 January 2021

Cytokine and gene transcription profiles of immune responses elicited by HIV lipopeptide vaccine in HIV-negative volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.102

7 January 2021

Identifiers

10.1016/J.VACCINE.2013.06.102

1 reference

Europe PubMed Central

19 October 2017

1 reference

Europe PubMed Central

19 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42284108&oldid=1569187988"